Results 161 to 170 of about 14,552,495 (294)
Review Of Soviet Zion: The Quest For A Russian Jewish Homeland By A. L. Kagedan [PDF]
Weinberg, Robert
core +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Review Of God Speed The Plough: The Representation Of Agrarian England, 1500-1660 By A. McRae [PDF]
DuPlessis, Robert S.
core +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
The association between family history of hypertension and diabetic kidney disease in patients with diabetes: a cross-sectional study. [PDF]
Xing Y, Yang X, Zhao Q.
europepmc +1 more source
Tumor mutational burden as a determinant of metastatic dissemination patterns
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal +4 more
wiley +1 more source
Family history of cardiovascular disease and its modifiable risk factors and association with offspring risk profile. [PDF]
Khajeh M +5 more
europepmc +1 more source
Review Of Commercialization And Agricultural Development: Central And Eastern China, 1870-1937 By L. Brandt [PDF]
Li, Lillian M.
core +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

